Atomic Force Microscopy Reveals Protein Folding
Credit: The Perkins group and Steve Burrows, JILA
The Perkins group continues to extend the performance of its unique Atomic Force Microscope (AFM) technology, revealing for the first time a dozen new short-lived intermediate states in the folding and unfolding of a membrane protein that controls the exchange of chemicals and ions into and out of living cells. Measuring the energetics and dynamics of membrane proteins is crucial to understanding normal physiology and disease, and the Perkins group’s observation of multiple new folding/unfolding states shines new light on these cellular “gatekeepers.”
The Perkins group used its recent 100-fold improvement in time resolution in AFM technology to probe the folding and unfolding of the protein bacteriorhodopsin, a key example of a membrane protein. Like all membrane proteins, bacteriorhodopsin exists in a thin membrane made of two layers of fat molecules called lipids. The group’s goal was to better understand the membrane proteins, which make up about 30% of the proteins expressed by an organism’s genome.
In living organisms, these membrane proteins thread through the fat layers in cell membranes, with one side facing the outside of the cell and the other the inside. This configuration allows the membrane proteins to control the exchange of chemicals into and out of the living cell. It also allows drugs to bind to the proteins on the cell’s exterior and cause structural changes that can alter the functioning of biomolecules inside the cell. For this reason, membrane proteins are targets of about 50% of current and future drug therapies.
Because membrane proteins are so important, the Perkins group wanted to understand membrane behavior inside their natural environment, i.e., a lipid bilayer. For nearly 20 years, researchers have been studying the behavior of these proteins with AFM. Bacteriorhodopsin, like many membrane proteins, contains seven helical structures that span the width of the lipid bilayer that separates the outside of the cell from the inside. And, in the last 15 years, researchers have seen just two structural variations, called intermediates, when unfolding a particular pair of these helices.
Now thanks to the Perkins’ group’s tremendous improvements in AFM instrumentation, the JILA team, led by research associate Hao Yu and graduate student Matt Siewny, saw at least 14 intermediates. Some intermediates along the unfolding pathway differed by only 2 amino-acid subunits, or half a helical turn. The group’s ability to see these intermediates occurred as a result of using its modified 9-µm-long AFM cantilevers. This innovation led to a 100-fold improvement in time resolution and a 10-fold improvement in temporal resolution in the group’s membrane-protein studies.
Not only are the membrane proteins folding on smaller structural scales than previously measured, but they are also unfolding and refolding on time scales much faster than could be resolved before now. The unfolding pathway of bacteriorhodopsin is incredibly more complicated than anyone had previously experimentally determined. However, molecular-dynamics theorists had previously predicted such complexity. It turns out that there is now good agreement between the group’s new experimental data and long-standing computational predictions of how a system like this should behave!
These new results were reported online in Science on March 2, 2017. The researchers responsible for the results include research associates Hao Yu and Devin Edwards, graduate student Matthew Siewny, Fellow Tom Perkins, and Aric Sanders of NIST.
Yu, H., Siewny, M. G. W., Edwards, D. T., Sanders, A. W., & Perkins, T. T. (2017). Hidden dynamics in the unfolding of individual bacteriorhodopsin proteins. Science, 355(6328), 945–950. doi:10.1126/science.aah7124
This article has been republished from materials provided by JILA. Note: material may have been edited for length and content. For further information, please contact the cited source.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE
Ataxin Links Long Term-Memory and NeurodegenerationNews
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)READ MORE